Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Albuterol MDPI in Pediatric Asthma
NCT02126839Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- May 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of albuterol spiromax in asthma, sponsored by Teva Pharmaceutical Industries Ltd.. Started May 2014; status: completed.
02
Drugs
albuterol spiromax
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02126839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126839.